# Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects

> **NCT01975337** · PHASE1 · COMPLETED · sponsor: **Debiopharm International SA** · enrollment: 16 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Alisporivir

## Key facts

- **NCT ID:** NCT01975337
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975337, "Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01975337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*